THLD Financial Facts
Net loss: -5.7MLoss from operations: -5.24M
See Full Income Statement
Restricted cash and other assets: 0
Total stockholders' equity: 22.92M
See Full Balance Sheet
Threshold Pharmaceuticals, Inc. (THLD) Earnings
|
Expand Research on THLD
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
8/1/16 | Q216 | -$0.10 | N/A | N/A | N/A | N/A | N/A | Details | |||
11/2/15 | Q315 | -$0.09 | -$0.14 | +$0.05 | $3.7M | $3.69M | N/A | Details | |||
3/3/15 | Q414 | -$0.12 | -$0.13 | +$0.01 | $3.7M | $4.1M | N/A | Details | |||
11/3/14 | Q314 | -$0.15 | -$0.12 | -$0.03 | $3.7M | $3.82M | N/A | Details | |||
3/6/14 | Q413 | -$0.13 | -$0.10 | -$0.03 | $3.2M | $3.58M | N/A | Details | |||
11/4/13 | Q313 | $0.02 | -$0.14 | +$0.16 | $3.2M | $3.15M | N/A | Details | |||
5/2/13 | Q113 | -$0.16 | -$0.09 | -$0.07 | $2.9M | $2.8M | N/A | Details | |||
11/2/12 | Q312 | -$0.06 | -$0.06 | $0.00 | $1.8M | $2.29M | N/A | Details |